|
8V3M
CCP5 apo structure
Deposited 2023-11-28
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–338(337 aa)
Chain A
425–605(181 aa)
|
Mutation:E516A,residues 339-424 replaced with a SGSGG loop
Mutation:E516A,residues 339-424 replaced with a SGSGG loop
|
MLT D-MALATE × 2
IMD IMIDAZOLE × 2
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;294 K;0.15 M DL-Malic acid, pH7.0, 0.1 M imidazole, pH7.0, 16% PEG MME 550
|
Resolution 1.80 Å
R-free 0.201
|
|
8V3O
CCP5 in complex with Glu-P-peptide 1 transition state analog
Deposited 2023-11-28
|
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–338(337 aa)
Chain A
425–605(181 aa)
|
Mutation:E516A,residues 339-424 replaced with a SGSGG loop
Mutation:E516A,residues 339-424 replaced with a SGSGG loop
|
ZN ZINC ION × 1
MLT D-MALATE × 2
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;294 K;0.15 M DL-Malic acid, pH7.0, 0.1 M imidazole, pH7.0, 16% PEG MME 550
|
Resolution 2.30 Å
R-free 0.227
|
|
8V3P
CCP5 in complex with Glu-P-peptide 2 transition state analog
Deposited 2023-11-28
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–338(337 aa)
Chain A
425–605(181 aa)
|
Mutation:E516A,construct is from residues 2-605,with residues 339-424 replaced with a SGSGG loop
Mutation:E516A,construct is from residues 2-605,with residues 339-424 replaced with a SGSGG loop
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;294 K;0.15 M DL-Malic acid, pH7.0, 0.1 M imidazole, pH7.0, 16% PEG MME 550
|
Resolution 2.36 Å
R-free 0.225
|
|
8V3Q
Structure of CCP5 class1
Deposited 2023-11-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–605(604 aa)
Fragment:residues 2-605
|
Mutation:E516A
|
ZN ZINC ION × 1
GLU GLUTAMIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|
|
8V3R
Structure of CCP5 class2
Deposited 2023-11-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–605(604 aa)
Fragment:residues 2-605
|
Mutation:E516A
|
ZN ZINC ION × 1
GLU GLUTAMIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
8V3S
Structure of CCP5 class3
Deposited 2023-11-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–605(604 aa)
Fragment:residues 2-605
|
Mutation:E516A
|
ZN ZINC ION × 1
GLU GLUTAMIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å
|
|
8V4K
CCP5 in complex with microtubules class1
Deposited 2023-11-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain E
2–605(604 aa)
Fragment:residues 2-605
|
Mutation:E516A
|
MG MAGNESIUM ION × 4
GTP GUANOSINE-5'-TRIPHOSPHATE × 2
G2P PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER × 2
ZN ZINC ION × 1
GLU GLUTAMIC ACID × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|
|
8V4L
CCP5 in complex with microtubules class2
Deposited 2023-11-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: hexameric
|
Chain E
2–605(604 aa)
Fragment:residues 2-605
|
Mutation:E516A
|
MG MAGNESIUM ION × 4
GTP GUANOSINE-5'-TRIPHOSPHATE × 2
G2P PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER × 2
GLU GLUTAMIC ACID × 1
ZN ZINC ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å
|
|
8V4M
CCP5 in complex with microtubules class3
Deposited 2023-11-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: hexameric
|
Chain E
2–605(604 aa)
Fragment:residues 2-605
|
Mutation:E516A
|
MG MAGNESIUM ION × 4
GTP GUANOSINE-5'-TRIPHOSPHATE × 2
G2P PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER × 2
GLU GLUTAMIC ACID × 1
ZN ZINC ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å
|